UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 151

Sortiert nach

Impact of Circadian Nuclear Receptor REV-ERBα on Midbrain Dopamine Production and Mood Regulation

Cell, 2014-05, Vol.157 (4), p.858-868

2014

Volltextzugriff (PDF)

Neuroprotective actions of sex steroids in Parkinson’s disease

Frontiers in neuroendocrinology, 2009-07, Vol.30 (2), p.142-157

2009

Volltextzugriff (PDF)

Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells

Journal of ethnopharmacology, 2007-05, Vol.111 (3), p.458-463

2007

Volltextzugriff (PDF)

Gender differences in Parkinson’s disease

Journal of neurology, neurosurgery and psychiatry, 2007-08, Vol.78 (8), p.819-824

2007

Volltextzugriff (PDF)

Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson’s disease

Frontiers in neuroendocrinology, 2012-04, Vol.33 (2), p.169-178

2012

Volltextzugriff (PDF)

Sex differences in methamphetamine toxicity in mice: Effect on brain dopamine signaling pathways

Psychoneuroendocrinology, 2011-08, Vol.36 (7), p.955-969

2011

Volltextzugriff (PDF)

OESTROGEN AND NIGROSTRIATAL DOPAMINERGIC NEURODEGENERATION: ANIMAL MODELS AND CLINICAL REPORTS OF PARKINSON'S DISEASE

Clinical and experimental pharmacology & physiology, 2007-07, Vol.34 (7), p.555-565

2007

Volltextzugriff (PDF)

Gender differences in methamphetamine use and responses: A review

Gender medicine, 2008-03, Vol.5 (1), p.24-35

2008

Volltextzugriff (PDF)

Estrogen Prevents Neuroprotection by Caffeine in the Mouse 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease

The Journal of neuroscience, 2006-01, Vol.26 (2), p.535-541

2006

Volltextzugriff (PDF)

Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice

Neuroscience letters, 2008-12, Vol.448 (1), p.130-133

2008

Volltextzugriff (PDF)

The effect of freezing and extraction upon striatal dopaminergic function

Journal of neuroscience methods, 2011-05, Vol.198 (1), p.23-28

Dluzen, Dean E.

2011

Volltextzugriff (PDF)

Parity decreases methamphetamine-induced striatal dopaminergic perturbation

Neurochemistry international, 2011-08, Vol.59 (2), p.101-103

Dluzen, Dean E.

2011

Volltextzugriff (PDF)

Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathways

Neuropharmacology, 2012-06, Vol.62 (7), p.2362-2371

2012

Volltextzugriff (PDF)

Unconventional effects of estrogen uncovered

Trends in pharmacological sciences (Regular ed.), 2005-10, Vol.26 (10), p.485-487

Dluzen, Dean E

2005

Volltextzugriff (PDF)

A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson's disease

PeerJ (San Francisco, CA), 2015-08, Vol.3, p.e1175-e1175

2015

Volltextzugriff (PDF)

Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice

Journal of Neural Transmission, 2008-06, Vol.115 (6), p.809-817

2008

Volltextzugriff (PDF)

Male/Female differences in neuroprotection and neuromodulation of brain dopamine

Frontiers in endocrinology (Lausanne), 2011, Vol.2, p.35-35

2011

Volltextzugriff (PDF)

Structure–activity relationship and docking studies of thiazolidinedione-type compounds with monoamine oxidase B

Bioorganic & medicinal chemistry letters, 2011-08, Vol.21 (16), p.4798-4803

2011

Volltextzugriff (PDF)

Methyl Yellow: A Potential Drug Scaffold for Parkinson's Disease

Chembiochem : a European journal of chemical biology, 2014-07, Vol.15 (11), p.1591-1598

2014

Volltextzugriff (PDF)

Dimebon attenuates methamphetamine, but not MPTP, striatal dopamine depletion

Neurochemistry international, 2012-06, Vol.60 (8), p.806-808

2012

Volltextzugriff (PDF)

Dopamine transporter function differences between male and female CD-1 mice

Brain research, 2005-02, Vol.1035 (2), p.188-195

2005

Volltextzugriff (PDF)

Estrogen, Testosterone, and Methamphetamine Toxicity

Annals of the New York Academy of Sciences, 2006-08, Vol.1074 (1), p.282-294

2006

Volltextzugriff (PDF)

Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system

Synapse (New York, N.Y.), 2006-10, Vol.60 (5), p.354-361

2006

Volltextzugriff (PDF)

Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity

Biochemical pharmacology, 2007-11, Vol.74 (9), p.1413-1423

2007

Volltextzugriff (PDF)

Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies

Endocrine, 2003-06, Vol.21 (1), p.67-76

2003

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(140)

Publikationsform

Sprache

Englisch
(151)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Animals
(116)
Science & Technology
(107)
Life Sciences & Biomedicine
(103)
Biological And Medical Sciences
(80)
Male
(80)
Neurosciences & Neurology
(77)
Neurosciences
(76)
Dopamine - Metabolism
(74)
Female
(70)
Rats
(54)
Fundamental And Applied Biological Sciences. Psychology
(52)
Mice
(52)
Corpus Striatum - Metabolism
(44)
Corpus Striatum - Drug Effects
(41)
Dopamine
(41)
Medical Sciences
(37)
Parkinson's Disease
(37)
Vertebrates: Nervous System And Sense Organs
(27)
Sex Characteristics
(26)
3,4-Dihydroxyphenylacetic Acid - Metabolism
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of Circadian Nuclear Receptor REV-ERBα on Midbrain Dopamine Production and Mood Regulation

Neuroprotective actions of sex steroids in Parkinson’s disease

Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells

Gender differences in Parkinson’s disease

Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson’s disease

Sex differences in methamphetamine toxicity in mice: Effect on brain dopamine signaling pathways

OESTROGEN AND NIGROSTRIATAL DOPAMINERGIC NEURODEGENERATION: ANIMAL MODELS AND CLINICAL REPORTS OF PARKINSON'S DISEASE

Gender differences in methamphetamine use and responses: A review

Estrogen Prevents Neuroprotection by Caffeine in the Mouse 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease

Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice

The effect of freezing and extraction upon striatal dopaminergic function

Parity decreases methamphetamine-induced striatal dopaminergic perturbation

Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathways

Unconventional effects of estrogen uncovered

A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson's disease

Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice

Male/Female differences in neuroprotection and neuromodulation of brain dopamine

Structure–activity relationship and docking studies of thiazolidinedione-type compounds with monoamine oxidase B

Methyl Yellow: A Potential Drug Scaffold for Parkinson's Disease

Dimebon attenuates methamphetamine, but not MPTP, striatal dopamine depletion

Dopamine transporter function differences between male and female CD-1 mice

Estrogen, Testosterone, and Methamphetamine Toxicity

Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system

Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity

Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies

Suchergebnisse filtern